Core Insights - Owens & Minor is selling a unit that provides medical supplies and services to healthcare providers for $375 million to Platinum Equity, with the sale expected to close by the end of 2025 [8] - The decision to sell was influenced by "inbound interest" from multiple parties, prompting a broader sale process [3] - The divested unit generated net revenue of $8 billion last year, while the retained patient direct business generated $2.7 billion, indicating a strategic shift towards potentially higher-margin operations [4] Financial Performance - The patient direct business, which Owens & Minor is retaining, had an operating income of $260 million last year, compared to $53 million for the divested unit [4] - The sale allows Owens & Minor to focus on its core business of delivering medical supplies directly to patients and home health agencies [8] Strategic Moves - Owens & Minor previously attempted to strengthen its patient direct unit by acquiring Rotech Healthcare Holdings for $1.36 billion, but the deal was terminated due to a Federal Trade Commission investigation [5] - The company plans to use the proceeds from the sale to pay down debt while remaining open to smaller acquisitions [6]